GB1592329A - Morphanthridines - Google Patents
Morphanthridines Download PDFInfo
- Publication number
- GB1592329A GB1592329A GB45932/77A GB4593277A GB1592329A GB 1592329 A GB1592329 A GB 1592329A GB 45932/77 A GB45932/77 A GB 45932/77A GB 4593277 A GB4593277 A GB 4593277A GB 1592329 A GB1592329 A GB 1592329A
- Authority
- GB
- United Kingdom
- Prior art keywords
- compound
- formula
- compounds
- free base
- addition salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 34
- 239000002253 acid Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 150000003839 salts Chemical group 0.000 claims description 7
- 239000012458 free base Substances 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 239000008024 pharmaceutical diluent Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 4
- 239000008096 xylene Substances 0.000 description 4
- 239000003176 neuroleptic agent Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 230000000701 neuroleptic effect Effects 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- MKJIEFSOBYUXJB-HOCLYGCPSA-N (3S,11bS)-9,10-dimethoxy-3-isobutyl-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one Chemical compound C1CN2C[C@H](CC(C)C)C(=O)C[C@H]2C2=C1C=C(OC)C(OC)=C2 MKJIEFSOBYUXJB-HOCLYGCPSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 208000009132 Catalepsy Diseases 0.000 description 1
- 101000654316 Centruroides limpidus Beta-toxin Cll2 Proteins 0.000 description 1
- OBWGMKKHCLHVIE-UHFFFAOYSA-N Fluperlapine Chemical compound C1CN(C)CCN1C1=NC2=CC(F)=CC=C2CC2=CC=CC=C12 OBWGMKKHCLHVIE-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010047853 Waxy flexibility Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000002903 catalepsic effect Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000035873 hypermotility Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 229960005333 tetrabenazine Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/20—Dibenz [b, e] azepines; Hydrogenated dibenz [b, e] azepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1415776A CH624682A5 (enExample) | 1976-11-10 | 1976-11-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1592329A true GB1592329A (en) | 1981-07-08 |
Family
ID=4398460
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB16347/80A Expired GB1592330A (en) | 1976-11-10 | 1977-11-04 | Morphanthridine derivative |
| GB45932/77A Expired GB1592329A (en) | 1976-11-10 | 1977-11-04 | Morphanthridines |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB16347/80A Expired GB1592330A (en) | 1976-11-10 | 1977-11-04 | Morphanthridine derivative |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4308207A (enExample) |
| JP (1) | JPS5929076B2 (enExample) |
| AT (1) | AT366682B (enExample) |
| AU (1) | AU517829B2 (enExample) |
| BE (1) | BE860613A (enExample) |
| CA (1) | CA1086315A (enExample) |
| CH (1) | CH624682A5 (enExample) |
| CY (1) | CY1269A (enExample) |
| DE (1) | DE2748920C2 (enExample) |
| DK (1) | DK140724B (enExample) |
| ES (1) | ES463971A1 (enExample) |
| FI (1) | FI64143C (enExample) |
| FR (1) | FR2370745A1 (enExample) |
| GB (2) | GB1592330A (enExample) |
| HK (1) | HK32282A (enExample) |
| IE (1) | IE46262B1 (enExample) |
| IL (1) | IL53332A (enExample) |
| KE (1) | KE3472A (enExample) |
| MY (1) | MY8400056A (enExample) |
| NL (1) | NL175297C (enExample) |
| NZ (2) | NZ185642A (enExample) |
| PH (1) | PH13515A (enExample) |
| PT (1) | PT67247B (enExample) |
| SE (1) | SE435510B (enExample) |
| SG (1) | SG66584G (enExample) |
| SU (1) | SU686616A3 (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2125574C1 (ru) * | 1992-05-29 | 1999-01-27 | Лилли Индастриз Лимитед | Тиенобензодиазепины или их фармацевтически приемлемые соли, способ их получения и фармацевтическая композиция |
| RU2126801C1 (ru) * | 1992-01-17 | 1999-02-27 | Анджелини Ричерке С.п.А. Сосиета Консортиле | Алкильные производные тразодона, способ их получения, промежуточные соединения и фармацевтическая композиция |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3402060A1 (de) * | 1984-01-21 | 1985-08-01 | Dr. Karl Thomae Gmbh, 7950 Biberach | Substituierte 5,11-dihydro-6h-dibenz(b,e)azepin-6-one, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| GB8607684D0 (en) * | 1986-03-27 | 1986-04-30 | Ici America Inc | Thiazepine compounds |
| AU8854091A (en) * | 1990-10-10 | 1992-05-20 | Schering Corporation | Bis-benzo cyclohepta piperidylidene, piperidine and piperazine compounds, compositions and methods of use |
| CN1681388A (zh) * | 2002-09-18 | 2005-10-12 | Fmc有限公司 | 三环衍生物杀虫剂 |
| SG159390A1 (en) * | 2003-01-23 | 2010-03-30 | Acadia Pharm Inc | Use of n-desmethyclozapine to treat human neuropsychiatric disease |
| US20050085463A1 (en) * | 2003-01-23 | 2005-04-21 | Weiner David M. | Use of N-desmethylclozapine to treat human neuropsychiatric disease |
| US20050250767A1 (en) * | 2003-01-23 | 2005-11-10 | Weiner David M | Use of N-desmethylclozapine to treat human neuropsychiatric disease |
| WO2005063254A2 (en) | 2003-12-22 | 2005-07-14 | Acadia Pharmaceuticals Inc. | Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| US20050282800A1 (en) * | 2004-04-01 | 2005-12-22 | Bo-Ragnar Tolf | Method of synthesis and isolation of solid N-desmethylclozapine and crystalline forms thereof |
| WO2007053618A1 (en) * | 2005-10-31 | 2007-05-10 | Acadia Pharmaceuticals Inc. | Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL140242B (nl) * | 1963-03-01 | 1973-11-15 | Wander Ag Dr A | Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen. |
| US3389139A (en) * | 1963-06-14 | 1968-06-18 | Wander Ag Dr A | 6-homopiperazino and piperazinomorphanthridines |
| GB1006156A (en) * | 1963-06-14 | 1965-09-29 | Wander Ag Dr A | 6-basic substituted morphanthridines |
| US3539573A (en) * | 1967-03-22 | 1970-11-10 | Jean Schmutz | 11-basic substituted dibenzodiazepines and dibenzothiazepines |
| US3962248A (en) * | 1972-04-04 | 1976-06-08 | Sandoz, Inc. | Process for making 11-piperazino-diazepines, oxazepines, thiazepines and azepines |
| CH601287A5 (enExample) * | 1975-08-06 | 1978-07-14 | Sandoz Ag |
-
1976
- 1976-11-10 CH CH1415776A patent/CH624682A5/de not_active IP Right Cessation
-
1977
- 1977-11-01 DK DK485677AA patent/DK140724B/da not_active IP Right Cessation
- 1977-11-01 FI FI773273A patent/FI64143C/fi not_active IP Right Cessation
- 1977-11-02 SE SE7712387A patent/SE435510B/xx unknown
- 1977-11-02 DE DE2748920A patent/DE2748920C2/de not_active Expired
- 1977-11-04 CY CY1269A patent/CY1269A/xx unknown
- 1977-11-04 NL NLAANVRAGE7712171,A patent/NL175297C/xx not_active IP Right Cessation
- 1977-11-04 GB GB16347/80A patent/GB1592330A/en not_active Expired
- 1977-11-04 GB GB45932/77A patent/GB1592329A/en not_active Expired
- 1977-11-08 IE IE2279/77A patent/IE46262B1/en unknown
- 1977-11-08 FR FR7733524A patent/FR2370745A1/fr active Granted
- 1977-11-08 IL IL53332A patent/IL53332A/xx unknown
- 1977-11-08 CA CA290,464A patent/CA1086315A/en not_active Expired
- 1977-11-08 PT PT67247A patent/PT67247B/pt unknown
- 1977-11-08 PH PH20407A patent/PH13515A/en unknown
- 1977-11-08 AU AU30467/77A patent/AU517829B2/en not_active Expired
- 1977-11-08 NZ NZ185642A patent/NZ185642A/xx unknown
- 1977-11-08 JP JP52133151A patent/JPS5929076B2/ja not_active Expired
- 1977-11-08 BE BE182454A patent/BE860613A/xx not_active IP Right Cessation
- 1977-11-08 NZ NZ191043A patent/NZ191043A/xx unknown
- 1977-11-08 ES ES463971A patent/ES463971A1/es not_active Expired
- 1977-11-09 SU SU2539049A patent/SU686616A3/ru active
- 1977-11-09 AT AT0799177A patent/AT366682B/de active
-
1980
- 1980-01-11 US US06/111,459 patent/US4308207A/en not_active Expired - Lifetime
-
1982
- 1982-07-15 HK HK322/82A patent/HK32282A/xx unknown
-
1984
- 1984-09-20 SG SG665/84A patent/SG66584G/en unknown
- 1984-10-17 KE KE3472A patent/KE3472A/xx unknown
- 1984-12-30 MY MY56/84A patent/MY8400056A/xx unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2126801C1 (ru) * | 1992-01-17 | 1999-02-27 | Анджелини Ричерке С.п.А. Сосиета Консортиле | Алкильные производные тразодона, способ их получения, промежуточные соединения и фармацевтическая композиция |
| RU2125574C1 (ru) * | 1992-05-29 | 1999-01-27 | Лилли Индастриз Лимитед | Тиенобензодиазепины или их фармацевтически приемлемые соли, способ их получения и фармацевтическая композиция |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1592329A (en) | Morphanthridines | |
| SK279058B6 (sk) | Substituovaný n-[(2-morfolynyl)alkyl]banzamidový d | |
| GB2145416A (en) | Benzoic acid derivatives | |
| EP0054951A1 (en) | Dibenz(b,f)(1,4)oxazepine derivatives, process for preparing the same, and pharmaceutical compositions comprising the same | |
| US4210648A (en) | II-Aminoacyl-5,11-dihydro-6H-pyrido(2,3-B) (1,4)benzodiazepin-6-ones and salts thereof | |
| EP0193148A2 (en) | 8-Chlorodibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid, 2-(alkoxy-containing acyl)hydrazides | |
| NZ195423A (en) | 6-phenyl-1,2,3,4,5,6-hexahydroazepino(4,5-b)indoles | |
| GB2081264A (en) | 5,10-dihydro-11h-dibenzo(b,e)(1,4)-diazepine-11-ones | |
| US4406900A (en) | Neuroleptic use of morphanthridines | |
| GB2078715A (en) | N-(diethylaminoethyl)-2-alkoxybenzamide derivatives | |
| CA1203537A (en) | Process for the preparation of 2-piperazinopyrimidine derivatives | |
| HU214869B (hu) | Eljárás 11-helyettesített-20,21-dinoreburnamenin-származékok és a vegyületeket tartalmazó gyógyászati készítmények előállítására | |
| CA2197172A1 (en) | Novel alkylamino derivatives as sigma 2 selective ligands | |
| GB1596170A (en) | 1,2,3,4,4a,10b-hexahydro-benz(f)isouqinolines | |
| IE43727B1 (en) | Dibenzo/b,e//1,4/diazepines | |
| GB1562831A (en) | Azabicyclo (3,1,0) hexane derivatives | |
| US4032640A (en) | 4H-Benzo[4,5]cyclohepta[1,2-b]thiophenes | |
| IE46263B1 (en) | A morphanthridine derivative | |
| US3917833A (en) | Amino-substituted benzocycloheptenones for inducing sleep | |
| Burke et al. | 2, 3-Dihydro-1H-imidazo [1.5-a] pyrroles. Condensation of Pyrroles and Formaldehyde and Primary Amines | |
| GB1600748A (en) | Benzazepine derivatives | |
| US4031225A (en) | 4H-Benzo[4,5]cyclohepta[1,2-b]thiophenes | |
| US4061752A (en) | 6-Piperazino-11-methylene-dibenzazepines[b,e] | |
| IE46688B1 (en) | N-(2,3 -dihydro-9-ergolen-8 -yl methyl)ureas | |
| US3505314A (en) | N-heterocyclic compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |